The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.
No Comments »
Filed under: Women's Health
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM). This new information is an important step, say [...]
No Comments »
Filed under: Women's Health
“[J]ust as the prognosis for our health care system is beginning to look sunnier, yet another complication has emerged: so far, reform legislation has failed to require insurers to cover some basic preventive services for women, or prevent providers from charging extra for them,” Sharon Lerner, author of the upcoming book “The War on Moms: [...]
No Comments »
Filed under: Women's Health
The following summarizes selected women’s health-related blog entries. “Some U.S.
No Comments »
Filed under: Women's Health
The sexual function of male rodents can be impaired by in utero and/or neonatal exposure to external molecules that disrupt normal hormone functioning, giving rise to concerns that low-level exposure to such molecules might cause similar effects in humans. Examples of such molecules include the synthetic nonsteroidal estrogen DES, which was used as a treatment [...]
No Comments »
Filed under: Men's Health
WASHINGTON (MedPage Today) — The FDA issued a warning letter to a drug manufacturer because of illegally marketed vitamin C-combination cold and flu medicines.
No Comments »
Filed under: Pharmacy News
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held November 15-19, 2009 in Boston, Massachusetts. Presentations are listed below.
No Comments »
Filed under: Pharmacy News
Texas State University and Orizon Research Institute announced the signing of an agreement today that will permit University Researchers to continue efforts through in vivo testing to further determine the potential and effectiveness of ALKA-V6, a compound which has shown remarkable ability to kill cancer cells and inhibit the HIV virus in laboratory experiments.
No Comments »
Filed under: Pharmacy News
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is [...]
No Comments »
Filed under: Pharmacy News
Schering-Plough Corporation today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a [...]
No Comments »
Filed under: Pharmacy News
